{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:34:32Z","timestamp":1761845672794,"version":"3.41.2"},"reference-count":24,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T00:00:00Z","timestamp":1673481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["22HA1003"],"award-info":[{"award-number":["22HA1003"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP20K07875"],"award-info":[{"award-number":["JP20K07875"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>We herein detail our experience with a unique patient with a primary central nervous system (PCNS) B-cell lymphoma concomitant with anti-<jats:italic>N<\/jats:italic>-methyl-<jats:sc>d<\/jats:sc>-aspartate receptor (NMDAR) antibodies that satisfied the criteria of \u201cprobable anti-NMDAR encephalitis (ProNMDARE)\u201d based on the Graus criteria 2016.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case presentation<\/jats:title><jats:p>A 73-year-old Japanese woman presented with acute pyrexia, agitation, and disturbance of consciousness. She gradually developed a reduction in speech frequency and truncal dystonia causing abnormal posture. Brain magnetic resonance imaging (MRI) demonstrated high-intensity lesions in the bilateral frontal lobes, and her cerebrospinal fluid revealed mild pleocytosis. She was diagnosed with acute encephalitis and treated with acyclovir and intravenous dexamethasone; however, no improvement was observed. She was transferred to our hospital 6 weeks after the onset of her symptoms, and anti-NMDAR antibodies were identified in her cerebrospinal fluid through indirect immunolabeling with rat brain frozen sections and cell-based assays with NR1\/NR2 transfected HEK cells. Follow-up MRI showed enlargement of the lesions in the right frontal lobe with gadolinium enhancement, suggesting a brain tumor. Stereotactic surgery was implemented, with subsequent pathological examination revealing that the tumor was consistent with diffuse large B-cell lymphoma (DLBCL) without evidence of systemic satellite lesions. Stereotactic irradiative therapies were then added to her treatment regimen, which partly improved her neurological symptoms with only mild cognitive dysfunction still remaining. A decrease in anti-NMDAR antibody titer was also confirmed after immunotherapy and tumor removal.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>We herein report our experience with a novel case of PCNS-DLBCL masquerading as anti-NMDAR encephalitis that satisfied the diagnostic criteria of \u201cproNMDARE.\u201d Treatment, including tumor removal, ameliorated disease severity and antibody titers of the patient. Our findings suggest that anti-NMDAR antibody-associated autoimmunity can be triggered by PCNS B-cell tumors, although primary brain tumors need to be excluded before establishing a diagnosis of autoimmune encephalitis.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fneur.2022.1048953","type":"journal-article","created":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T06:04:06Z","timestamp":1673503446000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Case report: Anti-N-methyl-D-aspartate receptor antibody-associated autoimmunity triggered by primary central nervous system B-cell lymphoma"],"prefix":"10.3389","volume":"13","author":[{"given":"Yuki","family":"Yokota","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Hara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natsuki","family":"Oshita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomotaka","family":"Mizoguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruna","family":"Nishimaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Hao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideto","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,1,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S1474-4422(10)70253-2","article-title":"Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis","volume":"10","author":"Dalmau","year":"2011","journal-title":"Lancet Neurol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/s1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"712","DOI":"10.5692\/clinicalneurol.53.712","article-title":"Glioblastoma with ovarian teratoma having N-methyl-d-aspartate receptor (NMDAR) antibody in CSF\u2014a case report","volume":"53","author":"Fujii","year":"2013","journal-title":"Rinsho Shinkeigaku."},{"key":"B4","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jns.2019.01.014","article-title":"Lymphomatosis cerebri and anti-NMDAR antibodies: a unique constellation","volume":"398","author":"Mariotto","year":"2019","journal-title":"J Neurol Sci."},{"key":"B5","doi-asserted-by":"publisher","first-page":"e1386","DOI":"10.1212\/WNL.0000000000005329","article-title":"Clinical and pathogenic significance of IgG, IgA, and IgM antibodies against the NMDA receptor","volume":"90","author":"Hara","year":"2018","journal-title":"Neurology."},{"key":"B6","doi-asserted-by":"publisher","first-page":"845272","DOI":"10.3389\/fimmu.2022.845272","article-title":"Novel qEEG biomarker to distinguish anti-NMDAR encephalitis from other types of autoimmune encephalitis","volume":"13","author":"Mizoguchi","year":"2022","journal-title":"Front Immunol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1212\/WNL.0b013e3181c55e9b","article-title":"Limbic encephalitis associated with antibodies to the NMDA receptor in Hodgkin lymphoma","volume":"73","author":"Zandi","year":"2009","journal-title":"Neurology."},{"key":"B8","doi-asserted-by":"publisher","first-page":"e1964","DOI":"10.1212\/WNL.0000000000005614","article-title":"Encephalitis with mGluR5 antibodies: symptoms and antibody effects","volume":"90","author":"Spatola","year":"2018","journal-title":"Neurology."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1212\/WNL.0000000000003796","article-title":"DPPX antibody-associated encephalitis: main syndrome and antibody effects","volume":"88","author":"Hara","year":"2017","journal-title":"Neurology."},{"key":"B10","doi-asserted-by":"publisher","first-page":"658","DOI":"10.3389\/fneur.2018.00658","article-title":"Primary B cell lymphoma of the CNS mimicking anti-LGI1 limbic encephalitis","volume":"9","author":"Thomas","year":"2018","journal-title":"Front Neurol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1056\/NEJM200001063420104","article-title":"Paraneoplastic cerebellar ataxia due to autoantibodies against a glutamate receptor","volume":"342","author":"Sillevis Smitt","year":"2000","journal-title":"N Engl J Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"3230","DOI":"10.1182\/blood-2014-03-537506","article-title":"Paraneoplastic neurological syndromes in Hodgkin and non-Hodgkin lymphomas","volume":"123","author":"Graus","year":"2014","journal-title":"Blood."},{"key":"B13","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/ana.21050","article-title":"Paraneoplastic anti-N-methyl-d-aspartate receptor encephalitis associated with ovarian teratoma","volume":"61","author":"Dalmau","year":"2007","journal-title":"Ann Neurol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1056\/NEJMra1708712","article-title":"Antibody-mediated encephalitis","volume":"378","author":"Dalmau","year":"2018","journal-title":"N Engl J Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S1474-4422(13)70282-5","article-title":"Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study","volume":"13","author":"Gresa-Arribas","year":"2014","journal-title":"Lancet Neurol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s12883-019-1436-x","article-title":"Brain astrocytoma misdiagnosed as anti-NMDAR encephalitis: a case report","volume":"19","author":"Lu","year":"2019","journal-title":"BMC Neurol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","article-title":"Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study","volume":"12","author":"Titulaer","year":"2013","journal-title":"Lancet Neurol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1002\/ana.23689","article-title":"N-methyl-d-aspartate receptor antibodies in herpes simplex encephalitis","volume":"72","author":"Pruss","year":"2012","journal-title":"Ann Neurol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/ana.24083","article-title":"Herpes simplex virus encephalitis is a trigger of brain autoimmunity","volume":"75","author":"Armangue","year":"2014","journal-title":"Ann Neurol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1212\/WNL.0b013e3182a9f531","article-title":"Herpes simplex virus-1 encephalitis can trigger anti-NMDA receptor encephalitis: case report","volume":"81","author":"Leypoldt","year":"2013","journal-title":"Neurology."},{"key":"B21","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1002\/mds.25626","article-title":"N-methyl-d-aspartate receptor antibodies in post-herpes simplex virus encephalitis neurological relapse","volume":"29","author":"Hacohen","year":"2014","journal-title":"Mov Disord."},{"key":"B22","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1002\/mds.25623","article-title":"Herpes simplex encephalitis relapse with chorea is associated with autoantibodies to N-methyl-d-aspartate receptor or dopamine-2 receptor","volume":"29","author":"Mohammad","year":"2014","journal-title":"Mov Disord."},{"key":"B23","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.jpeds.2012.10.011","article-title":"Pediatric anti-N-methyl-d-aspartate receptor encephalitis-clinical analysis and novel findings in a series of 20 patients","volume":"162","author":"Armangue","year":"2013","journal-title":"J Pediatr."},{"key":"B24","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9","article-title":"The Ki-67 protein: from the known and the unknown","volume":"182","author":"Scholzen","year":"2000","journal-title":"J Cell Physiol."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.1048953\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T06:04:13Z","timestamp":1673503453000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.1048953\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,12]]},"references-count":24,"alternative-id":["10.3389\/fneur.2022.1048953"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2022.1048953","relation":{},"ISSN":["1664-2295"],"issn-type":[{"type":"electronic","value":"1664-2295"}],"subject":[],"published":{"date-parts":[[2023,1,12]]},"article-number":"1048953"}}